同步财经ACHV
Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters’ Option to Purchase Additional Securities
时间：2025-07-01 07:52:40 市场： 美股 综合
Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering
时间：2025-06-27 11:43:35 市场： 美股 综合
Achieve Life Sciences Inc - Offering Price Set at $3.00 per Share and Warrant
时间：2025-06-27 11:43:35 市场： 美股 综合
Achieve Life Sciences Announces Proposed Underwritten Public Offering
时间：2025-06-27 04:03:00 市场： 美股 综合
Achieve Life Sciences Announces Partnership With Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades
时间：2025-06-27 04:02:00 市场： 美股 综合
Achieve Life Sciences Announces Submission of Nda to FDA for Cytisinicline as a Treatment of Nicotine Dependence for Smoking Cessation
时间：2025-06-27 04:01:45 市场： 美股 综合
Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the Orca-Ol Clinical Trial
时间：2025-02-10 21:30:00 市场： 美股 综合
Achieve Life Sciences Appoints DR. Kristen Slaoui and Nancy Phelan to Its Board of Directors
时间：2025-01-10 21:30:02 市场： 美股 综合
Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer
时间：2024-12-09 21:30:01 市场： 美股 综合
Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline
时间：2024-10-16 20:00:02 市场： 美股 综合